Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Center for Stress and Neural Regulation of Reproductive Aging Health Outcomes
Engraftment and in vivo selection of HIV-protected stem cells
Defining the Contribution of ENaC to ADH-mediated Water and Sodium Excretion
Subcellular Domains of Myelinating-Glia: Capturing Axonal Contact.
Transgenic Mouse Model for Barrett's Esophagus
Recently added grants:
Computational Modeling of Right Ventricular Intracardiac Flow in Tetralogy of Fallot
Investigating membrane repair capacity in facioscapulohumeral muscular dystrophy
Effectiveness of an Empirically Supported Family Intervention: Mental Health Outcomes, Mechanisms of Effect, and Organizational Factors
Toxicity testing of fresh and photochemically aged burn pit smoke emissions
Sex separation through targeting of conserved female-specific lethal genes in disease vector mosquitoes
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35008-12-0-1
Application #
7577651
Study Section
Project Start
2003-02-18
Project End
2008-02-17
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
/
$57,513
NIH 2007
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction Clinical Stu
Hurwityz, Daniel /
$64,187
NIH 2007
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
/
Comments
Be the first to comment on this grant